EBV |
Epstein-Barr virus |
LMPs |
Latent membrane proteins |
EBNAs |
Epstein-Barr virus nuclear antigens |
NPC |
Nasopharyngeal carcinoma |
IKK |
Inhibitory-κB kinase |
NF-κB |
Nuclear factor kappa B |
CTARs |
C-terminal activation regions |
STAT |
Signal transducer and activator of transcription |
PI3K |
Phosphatidylinositol 3-kinase |
BL |
Burkitt’s lymphoma |
UICC |
Union for International Cancer Control |
AJCC |
American Joint Committee on Cancer |
TNM |
Tumor, node, and metastasis |
JAK |
Janus kinase |
mTOR |
Mammalian target of rapamycin |
EGFR |
Epidermal growth factor receptor |
MAPK |
Mitogen-activated protein kinase |
NHLs |
Non-Hodgkin’s lymphomas |
TCLs |
T-cell lymphomas |
PTCLs |
Peripheral T-cell lymphomas |
CTCLs |
Cutaneous T-cell lymphomas |
AITL |
Angioimmunoblastic T-cell lymphoma |
PD-L1 |
Programmed death-ligand 1 |
PTEN |
Phosphatase and tensin homolog |
CDKN2 |
Cyclin-dependent kinase inhibitor 2 |
Myc |
Master regulator of cell cycle entry and proliferative metabolism |
Bcl-2 |
B-cell lymphoma 2 |
Mdm2 |
Mouse double minute 2 homolog |
USP7 |
Ubiquitin-specific-processing protease 7 |
TRAF2 |
Tumor necrosis factor receptor-associated factor 2 |
DNMT1 |
DNA methyltransferase 1 |
DKK1 |
Dickkopf protein family |